0.45Open1.00Pre Close5 Volume388 Open Interest45.00Strike Price251.00Turnover54.76%IV6.80%PremiumJul 19, 2024Expiry Date0.00Intrinsic Value100Multiplier11DDays to Expiry0.55Extrinsic Value100Contract SizeAmericanOptions Type0.3175Delta0.0844Gamma51.70Leverage Ratio-0.0658Theta0.0042Rho16.41Eff Leverage0.0275Vega
Agios Pharmaceuticals Stock Discussion
HOW MANY STUPID TRADERS HERE, LOSING AND STILL TRADING 🤔🤔🤔
Bad Demon Trap = Xi Zor Gai 😏
$Ironwood Pharmaceuticals(IRWD.US)$ Phase 3
$Liquidia(LQDA.US)$ Phase 3
$United Therapeutics(UTHR.US)$ Phase 3
$MorphoSys(MOR.US)$ Phase 3
$Immunocore(IMCR.US)$ Phase 3
$Crinetics(CRNX.US)$ Phase 3
$UroGen Pharma Ltd(URGN.US)$ Phase 3
$AstraZeneca(AZN.US)$ Phase 3
$AstraZeneca(AZN.US)$ Phase 3
$AstraZeneca(AZN.US)$ Phase 3
$AstraZeneca(AZN.US)$ Phase 3
$Capricor Therapeutics(CAPR.US)$ Phase 3
$Annexon(ANNX.US)$ Phase 3
$Lipocine(LPCN.US)$ Phase 3 ...
In reaction to earnings/guidance:
• $AutoZone(AZO.US)$ +2.7%, $Jacobs Engineering(J.US)$ +0.9% (reaffirms Q4 EPS and adjusted EBITDA guidance)
Other news:
• $Purple Innovation(PRPL.US)$ +32.6% (confirms it received an unsolicited, non-binding proposal from Coliseum Capital Management to acquire all of the outstanding capital stock of Purple for $4.35 per share)
• $KnowBe4(KNBE.US)$ +24.9% (received a non-binding proposal f...
In reaction to earnings/guidance:
• $Foot Locker(FL.US)$ +19.7%, $BILL Holdings(BILL.US)$ +18.1% (also names new COO), $Buckle Inc(BKE.US)$ +1.7%
Other news:
• $Axsome Therapeutics(AXSM.US)$ +33.8% (announces FDA approval of AUVELITY the first and only oral nmda receptor antagonist for the treatment of major depressive disorder in adults)
• $SpringWorks Therapeutics(SWTX.US)$ +4.9% (late-breaking oral presentation of phase 3 DeFi da...
No comment yet